| scholarly article | Q13442814 |
| P2093 | author name string | Buxing Chen | |
| Huiyong Yin | |||
| Lemin Zheng | |||
| Qun Chen | |||
| Tingting Chen | |||
| Mingming Zhao | |||
| Lin Xia | |||
| Zhengjiang Zhu | |||
| Shuyuan Guo | |||
| Jianhong Lu | |||
| Xinli Xue | |||
| P2860 | cites work | Eicosanoid storm in infection and inflammation | Q26851985 |
| Metabolomics and cardiovascular biomarker discovery | Q26991473 | ||
| The influence of innate and adaptive immune responses on atherosclerosis | Q27000370 | ||
| Prostaglandins and leukotrienes: advances in eicosanoid biology | Q28208246 | ||
| Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease | Q28260195 | ||
| Intervention Trials with the Mediterranean Diet in Cardiovascular Prevention: Understanding Potential Mechanisms through Metabolomic Profiling | Q28274033 | ||
| The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity | Q28286359 | ||
| Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics | Q28300402 | ||
| Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages | Q28537901 | ||
| Macrophages in the pathogenesis of atherosclerosis | Q29617765 | ||
| Atherosclerosis. the road ahead | Q29618972 | ||
| CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets | Q30318255 | ||
| Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2. | Q30423924 | ||
| New insights regarding the autoxidation of polyunsaturated fatty acids | Q33432753 | ||
| Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro | Q33852491 | ||
| Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates: Z,E/E,E stereoisomer ratios. | Q33918421 | ||
| Myeloperoxidase-generated oxidants and atherosclerosis | Q34006268 | ||
| Phospholipase A2 regulates eicosanoid class switching during inflammasome activation | Q34144445 | ||
| Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 | ||
| The emerging roles of PAF acetylhydrolase | Q34847192 | ||
| Isoprostane generation and function | Q35332267 | ||
| The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field. | Q35544562 | ||
| Phospholipid oxidation generates potent anti-inflammatory lipid mediators that mimic structurally related pro-resolving eicosanoids by activating Nrf2. | Q35577209 | ||
| Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans | Q35980355 | ||
| Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans | Q36239453 | ||
| Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids | Q36263522 | ||
| Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis | Q36348728 | ||
| Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid | Q36477710 | ||
| Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease | Q36663530 | ||
| Identification of metabolic biomarkers in patients with type 2 diabetic coronary heart diseases based on metabolomic approach | Q37137243 | ||
| Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk | Q37334501 | ||
| Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method | Q37359777 | ||
| Metabolism and atherogenic disease association of lysophosphatidylcholine | Q37537825 | ||
| Free radical lipid peroxidation: mechanisms and analysis | Q37921265 | ||
| Role of phospholipid oxidation products in atherosclerosis | Q38039282 | ||
| Role of mitochondria in programmed cell death mediated by arachidonic acid-derived eicosanoids | Q38051928 | ||
| Proteomics and metabolomics for mechanistic insights and biomarker discovery in cardiovascular disease | Q38207813 | ||
| Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myo | Q39973571 | ||
| Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association | Q40061255 | ||
| Increases in Plasma Tryptophan Are Inversely Associated with Incident Cardiovascular Disease in the Prevención con Dieta Mediterránea (PREDIMED) Study | Q40343646 | ||
| Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study | Q41062475 | ||
| Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis | Q41372923 | ||
| Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins | Q41937076 | ||
| Arginine methylation dysfunction increased risk of acute coronary syndrome in coronary artery disease population: A case-control study | Q42040317 | ||
| Identification of intact oxidation products of glycerophospholipids in vitro and in vivo using negative ion electrospray iontrap mass spectrometry | Q42574875 | ||
| Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety in vitro and in vivo: Implication in atherosclerosis | Q42775756 | ||
| Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events | Q43155073 | ||
| Simultaneous analysis of multiple lipid oxidation products in vivo by liquid chromatographic-mass spectrometry (LC-MS). | Q43219685 | ||
| A role for oxidized phospholipids in atherosclerosis | Q43686230 | ||
| Oxidized low-density lipoprotein and atherosclerosis | Q43816762 | ||
| A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. | Q44081169 | ||
| Mass spectrometry-based metabolomic profiling identifies alterations in salivary redox status and fatty acid metabolism in response to inflammation and oxidative stress in periodontal disease | Q46151568 | ||
| Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome | Q46441367 | ||
| Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production? | Q51304004 | ||
| Quantitative Metabolomic Profiling of Plasma, Urine, and Liver Extracts by 1H NMR Spectroscopy Characterizes Different Stages of Atherosclerosis in Hamsters. | Q51545480 | ||
| Comprehensive Metabolomic Characterization of Coronary Artery Diseases. | Q51807686 | ||
| Human Platelet Lipidomics: Variance, Visualization, Flux, and Fuel. | Q53099740 | ||
| Low serum tryptophan predicts higher mortality in cardiovascular disease. | Q53638477 | ||
| Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry | Q56974325 | ||
| Linoleic acid peroxidation--the dominant lipid peroxidation process in low density lipoprotein--and its relationship to chronic diseases | Q77682968 | ||
| Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans | Q79362550 | ||
| Effects of thyroid hormone status on metabolic pathways of arachidonic acid in mice and humans: A targeted metabolomic approach | Q87053382 | ||
| Caveats of Untargeted Metabolomics for Biomarker Discovery | Q88342922 | ||
| P921 | main subject | heart disease | Q190805 |
| metabolomics | Q12149006 | ||
| P304 | page(s) | 899-907 | |
| P577 | publication date | 2017-04-26 | |
| P1433 | published in | Redox Biology | Q27724751 |
| P1476 | title | Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases | |
| P478 | volume | 12 |
| Q77792400 | A cross sectional study evaluating psychosocial job stress and health risk in emergency department nurses |
| Q92156146 | Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury from Oxidative Stress by Regulating Succinate, Lysophospholipid Metabolism, and ROS Scavenging System |
| Q60303208 | Endogenous cholesterol ester hydroperoxides modulate cholesterol levels and inhibit cholesterol uptake in hepatocytes and macrophages |
| Q57182446 | Lipidomic insight into cardiovascular diseases |
| Q49832342 | Metabolic Predictors of Incident Coronary Heart Disease in Women. |
| Q89576028 | Metabolomic Approach to Redox and Nitrosative Reactions in Cardiovascular Diseases |
| Q58694190 | Metabolomics Study of the Biochemical Changes in the Plasma of Myocardial Infarction Patients |
| Q92282756 | Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease |
| Q51252064 | Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients. |
| Q64247254 | Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China |
| Q92858035 | The value of serum metabolomics analysis in predicting the response to cardiac resynchronization therapy |
Search more.